News
ALLK
0.3291
0.00%
0.0000
*News On Allakos Inc. (ALLK) Now Under CBIO.XX
Dow Jones · 05/15/2025 21:08
Allakos Completes Merger with Concentra Biosciences
TipRanks · 05/15/2025 13:49
Weekly Report: what happened at ALLK last week (0505-0509)?
Weekly Report · 05/12/2025 09:28
Weekly Report: what happened at ALLK last week (0428-0502)?
Weekly Report · 05/05/2025 09:28
Weekly Report: what happened at ALLK last week (0421-0425)?
Weekly Report · 04/28/2025 09:30
Weekly Report: what happened at ALLK last week (0414-0418)?
Weekly Report · 04/21/2025 09:30
Weekly Report: what happened at ALLK last week (0407-0411)?
Weekly Report · 04/14/2025 09:28
Weekly Report: what happened at ALLK last week (0331-0404)?
Weekly Report · 04/07/2025 09:28
Pliant Therapeutics: An Activist On Deck
Seeking Alpha · 04/03/2025 16:22
BUZZ-U.S. STOCKS ON THE MOVE-Sarepta, Amazon, Sportman's Warehouse
Reuters · 04/02/2025 18:40
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 04/02/2025 17:06
BUZZ-U.S. STOCKS ON THE MOVE-M-tron, Rocket Companies, TKO Group
Reuters · 04/02/2025 16:33
ALLAKOS INC SHARES RISE 44.8% TO 31 CENTS ON BUYOUT DEAL WITH CONCENTRA BIOSCIENCES
Reuters · 04/02/2025 13:31
BUZZ-Allakos soars on buyout deal with Concentra Biosciences
Reuters · 04/02/2025 13:21
Allakos Announces Merger Agreement with Concentra Biosciences
TipRanks · 04/02/2025 12:49
Allakos surges on reverse merger deal with Concentra Biosciences
Seeking Alpha · 04/02/2025 12:39
Allakos to Be Acquired for 33 Cents a Share
Dow Jones · 04/02/2025 12:35
Allakos Enters Agreement To Be Acquired By Concentra Biosciences For $0.33 In Cash Per Share. Merger Expected To Close In May 2025
Benzinga · 04/02/2025 12:12
*Allakos Officers, Directors, Affiliates Holding About 8.07% of Common Stk Have Signed Support Agreements
Dow Jones · 04/02/2025 12:07
Allakos to be acquired by Concentra Biosciences for 33c per share in cash
TipRanks · 04/02/2025 12:06
More
Webull provides a variety of real-time ALLK stock news. You can receive the latest news about Allakos through multiple platforms. This information may help you make smarter investment decisions.
About ALLK
Allakos Inc. is a biotechnology company. The Company is developing therapeutics that target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory and proliferative diseases.